Related Experiment Video
Updated: Aug 16, 2026

Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates
Published on: October 18, 2018
[Quantitative studies on dauricine block of cardiac sodium channels]
Abstract:
Quantitative studies on kinetics of dauricine (Dau) blockade of cardiac sodium channels based on the model of gate-related receptor hypothesis were performed by using computer simulation. The time constant of recovery from blocking of Dau at holding potential -80 mV was 9.8 s and increased with membrane potential hyperpolarization, which suggested that Dau might be trapped in channel by activation gate. The apparent rate of onset of blocking of Dau was 0.33/pulse at stimulation frequency of 1.0 Hz. These results showed that Dau blocks sodium channel in a fast-in-slow-out (FISO) fashion. The binding rate of drug-receptor at clamping potential -50 mV was 753 kL.mol-1.s-1, the unbinding rate was 32.86/s, with Kd of 44 mumol.L-1 which coincided reasonably with documented IC50 value of 46 mumol.L-1 for inhibition of sodium current. The studies also showed a shift by -4 mV on the mid-point of h infinity curve. All these studies lead us to suggest that the binding site of Dau in cardiac sodium channel is activation gate-related receptor site.
More Related Videos
Related Concept Videos
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Depolarizing Blockers: Pharmocokinetics
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...

